Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SmarTek21 is a private digital engineering and enterprise technology services company that builds custom software, modernizes legacy systems, and delivers AI-powered solutions for large enterprises. The company serves multiple verticals including healthcare and life sciences, where it provides EHR consulting, implementation, optimization, staffing, integration, and related enterprise AI services. Its broader offerings span product engineering, data and analytics, cloud, cybersecurity, and managed services. SmarTek21 appears to operate as a commercial technology and consulting business rather than a therapeutic biotech or pharmaceutical developer, with healthcare exposure centered on software and operational enablement rather than drug development. The company also references an IntelliTek AI platform family through its holdings structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SmarTek21.